One of the key challenges in cancer research is to find patients that will respond well to targeted drug therapy. Specific mutations in a patient’s tumor can be an indication of the patient’s potential responsiveness to such therapy.
In our recent blogpost we discussed an easy solution to set up a local instance of cBioPortal using Docker. The next step is to load a study into the database. In cBioPortal Datahub, there are plenty of public studies that have staging files[…]
CIViC, a resource for clinical interpretation of cancer variants, was added to cBioPortal by The Hyve. In the decade of precision medicine, accurate and clinically relevant information on variants in cancer patients is extremely important. This[…]
Last week we had the privilege of joining the first cBioPortal hackathon, hosted by Dana Farber Cancer Institute in Boston. The group (with developers from MSKCC, Dana Farber, The Hyve and Princess Margaret Cancer Centre) was divided into four[…]
The cBioPortal for Cancer Genomics is a well known, and well loved, interface for interactive analysis of cancer data. It has been developed, maintained and is also heavily used by the Memorial Sloan Kettering Cancer Center in New York.